BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11789024)

  • 21. Biodistribution of anti-breast mucin HuBrE3-derived inverted Fabs (IFabs) in nude mice carrying MX-1 xenografts.
    Speck RR; Blank EW; Couto JR
    Hybridoma; 1997 Jun; 16(3):243-8. PubMed ID: 9219034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.
    Buchegger F; Pèlegrin A; Delaloye B; Bischof-Delaloye A; Mach JP
    J Nucl Med; 1990 Jun; 31(6):1035-44. PubMed ID: 2348233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibitory effect of L-lysine on renal accumulation of 67Cu-labelled F(ab')2 fragments in mice.
    Rutherford RA; Smith A; Waibel R; Schubiger PA
    Int J Cancer; 1997 Jul; 72(3):522-9. PubMed ID: 9247299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of radioiodinated and radiocopper labeled monovalent fragments of monoclonal antibody chCE7 for targeting of neuroblastoma.
    Carrel F; Amstutz H; Novak-Hofer I; Schubiger PA
    Nucl Med Biol; 1997 Aug; 24(6):539-46. PubMed ID: 9316082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-linked monoclonal antibody fragment for improved tumor targeting.
    Stalteri MA; Mather SJ
    Bioconjug Chem; 1995; 6(2):179-86. PubMed ID: 7599261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.
    Zimmermann K; Grünberg J; Honer M; Ametamey S; Schubiger PA; Novak-Hofer I
    Nucl Med Biol; 2003 May; 30(4):417-27. PubMed ID: 12767399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
    Beyers M; Aspinall S; Conradie JD; Fourie PJ
    Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer.
    Bryan JN; Jia F; Mohsin H; Sivaguru G; Miller WH; Anderson CJ; Henry CJ; Lewis MR
    Nucl Med Biol; 2005 Nov; 32(8):851-8. PubMed ID: 16253810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
    Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy.
    Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T
    J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
    Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
    DeNardo GL; Kroger LA; Meares CF; Richman CM; Salako Q; Shen S; Lamborn KR; Peterson JJ; Miers LA; Zhong GR; DeNardo SJ
    Clin Cancer Res; 1998 Oct; 4(10):2483-90. PubMed ID: 9796981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
    Quadri SM; Vriesendorp HM
    Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of radiolabel on the in vivo processing of intact and fragmented anti-tumour monoclonal antibody.
    Smith A; Alberto R; Shubiger PA
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):54-8. PubMed ID: 7632768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model.
    Peräalä-Heape M; Vihko P; Vihko R
    Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.